SB36 Alabama 2011 Session

Summary

Primary Sponsor

Roger Bedford, Jr.

Democrat

Session

Regular Session 2011

Title

Controlled substances, ephedrine and pseudoephedrine included in Schedule III controlled substances, certain licensed wholesale drug distributors exempt from certain requirements of this act, Sec. 20-2-27 am'd.

Summary

SB36 would add ephedrine and pseudoephedrine to Schedule III controlled substances in Alabama and create a specific exemption for certain licensed wholesale drug distributors.

What This Bill Does

Ephedrine and pseudoephedrine would be added to Schedule III controlled substances in Alabama. Any product containing these substances would be regulated under Schedule III and subject to the same controls as other Schedule III substances. The bill also exempts certain licensed wholesale drug distributors from storage, reporting, record-keeping, and physical security requirements for these substances. The exemption applies to distributors licensed by the State Board of Pharmacy and registered with the DEA, and the act becomes effective on the first day of the third month after passage and governor approval.

Who It Affects

• Licensed wholesale drug distributors that are regulated by the Alabama State Board of Pharmacy and registered with the U.S. Drug Enforcement Administration (DEA) will be exempt from certain storage, reporting, record-keeping, and physical security requirements for controlled substances containing ephedrine or pseudoephedrine.
• All other entities handling ephedrine or pseudoephedrine (such as other wholesalers, pharmacies, manufacturers) would remain subject to the normal Schedule III controls and requirements.

Key Provisions

• Ephedrine and pseudoephedrine added to Schedule III controlled substances under Section 20-2-27.
• Any material containing ephedrine or pseudoephedrine is included in Schedule III.
• Certain licensed wholesale drug distributors, as defined (licensed by the State Board of Pharmacy and registered with the DEA), are exempt from storage, reporting, record-keeping, and physical security requirements related to these substances.
• The State Board of Health may exempt certain stimulant/depressant compounds from the act if they contain active medicinal ingredients without stimulant or depressant effects and do not increase abuse potential.
• Effective date: the act takes effect on the first day of the third month after passage and governor approval.

AI-generated summary using openai/gpt-5-nano on Feb 25, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances